Lower corporate costs also enabled the company to beat profit estimates, said RBC Capital Markets analyst Biraj Borkhataria.

ResMed (NYSE:RMD) received an updated price target from RBC Capital Markets following the disclosure of its second-quarter ...

In summary, RBC Capital finds Roper's valuation attractive at current levels, despite the market's general inclination ...

The acquisition of Chemelex, a manufacturer of electric heat tracing systems, was completed with an equity investment share of $210 million. Management cited this as an example of leveraging ...

Ltd has reported an after-tax net income of $1.166 billion for the fiscal year ended October 31, 2024, an increase of $91.1 ...

RBC Capital analyst Nik Modi maintained a Buy rating on The Estée Lauder Companies (EL – Research Report) today and set a price target of ...

In a report released yesterday, Nelson Ng from RBC Capital maintained a Hold rating on Methanex (MEOH – Research Report), with a price target ...

The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.

Geneos Wealth Management Inc. bought a new stake in shares of Bank of Montreal (NYSE:BMO – Free Report) (TSE:BMO) in the 4th ...

We recently compiled a list of the 10 AI News Updates Trending on Wall Street. In this article, we are going to take a look at where CGI Inc.

We recently published a list of Warren Buffett’s 10 Longest-Held Stocks. In this article, we are going to take a look at where Charter Communications, Inc.

Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a ...